Cross Country Healthcare Statistics
Total Valuation
CCRN has a market cap or net worth of $305.25 million. The enterprise value is $198.83 million.
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CCRN has 32.20 million shares outstanding. The number of shares has decreased by -2.91% in one year.
| Current Share Class | 32.20M |
| Shares Outstanding | 32.20M |
| Shares Change (YoY) | -2.91% |
| Shares Change (QoQ) | -0.58% |
| Owned by Insiders (%) | 7.71% |
| Owned by Institutions (%) | 83.71% |
| Float | 29.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 92.49 |
| PS Ratio | 0.29 |
| Forward PS | 0.31 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | 7.61 |
| P/OCF Ratio | 6.33 |
| PEG Ratio | 9.25 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.73, with an EV/FCF ratio of 4.96.
| EV / Earnings | n/a |
| EV / Sales | 0.19 |
| EV / EBITDA | 10.73 |
| EV / EBIT | 78.34 |
| EV / FCF | 4.96 |
Financial Position
The company has a current ratio of 3.78, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.78 |
| Quick Ratio | 3.61 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.06 |
| Interest Coverage | 1.15 |
Financial Efficiency
Return on equity (ROE) is -25.57% and return on invested capital (ROIC) is 0.96%.
| Return on Equity (ROE) | -25.57% |
| Return on Assets (ROA) | 0.31% |
| Return on Invested Capital (ROIC) | 0.96% |
| Return on Capital Employed (ROCE) | 0.68% |
| Weighted Average Cost of Capital (WACC) | 6.66% |
| Revenue Per Employee | $133,624 |
| Profits Per Employee | -$12,022 |
| Employee Count | 7,890 |
| Asset Turnover | 2.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CCRN has paid $11.34 million in taxes.
| Income Tax | 11.34M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.07% in the last 52 weeks. The beta is 0.34, so CCRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -35.07% |
| 50-Day Moving Average | 9.12 |
| 200-Day Moving Average | 11.05 |
| Relative Strength Index (RSI) | 51.96 |
| Average Volume (20 Days) | 416,016 |
Short Selling Information
The latest short interest is 1.34 million, so 4.17% of the outstanding shares have been sold short.
| Short Interest | 1.34M |
| Short Previous Month | 1.31M |
| Short % of Shares Out | 4.17% |
| Short % of Float | 4.52% |
| Short Ratio (days to cover) | 2.70 |
Income Statement
In the last 12 months, CCRN had revenue of $1.05 billion and -$94.85 million in losses. Loss per share was -$2.93.
| Revenue | 1.05B |
| Gross Profit | 213.57M |
| Operating Income | 2.54M |
| Pretax Income | -83.51M |
| Net Income | -94.85M |
| EBITDA | 18.53M |
| EBIT | 2.54M |
| Loss Per Share | -$2.93 |
Full Income StatementBalance Sheet
The company has $108.74 million in cash and $2.32 million in debt, with a net cash position of $106.42 million or $3.31 per share.
| Cash & Cash Equivalents | 108.74M |
| Total Debt | 2.32M |
| Net Cash | 106.42M |
| Net Cash Per Share | $3.31 |
| Equity (Book Value) | 322.82M |
| Book Value Per Share | 10.18 |
| Working Capital | 215.83M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $48.25 million and capital expenditures -$8.16 million, giving a free cash flow of $40.09 million.
| Operating Cash Flow | 48.25M |
| Capital Expenditures | -8.16M |
| Depreciation & Amortization | 15.99M |
| Net Borrowing | n/a |
| Free Cash Flow | 40.09M |
| FCF Per Share | $1.25 |
Full Cash Flow StatementMargins
Gross margin is 20.26%, with operating and profit margins of 0.24% and -9.00%.
| Gross Margin | 20.26% |
| Operating Margin | 0.24% |
| Pretax Margin | -7.92% |
| Profit Margin | -9.00% |
| EBITDA Margin | 1.76% |
| EBIT Margin | 0.24% |
| FCF Margin | 3.80% |
Dividends & Yields
CCRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.91% |
| Shareholder Yield | 2.91% |
| Earnings Yield | -31.07% |
| FCF Yield | 13.13% |
Analyst Forecast
The average price target for CCRN is $14.15, which is 49.26% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.15 |
| Price Target Difference | 49.26% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CCRN has an Altman Z-Score of 5.46 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.46 |
| Piotroski F-Score | 4 |
